BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 13713025)

  • 1. Presence of anti-C but no anti-D in a cde/cde mother giving birth to a CDe/cde baby.
    HEISTO H; KORNSTAD L
    Vox Sang; 1961 May; 6():298-303. PubMed ID: 13713025
    [No Abstract]   [Full Text] [Related]  

  • 2. THE USE OF AN ALBUMIN-ENHANCED INDIRECT ANTIGLOBULIN SYSTEM TO DETECT IMMUNE ANTI-A AND ANTI-D IN THE SERUM OF THE NEWBORN.
    HAMRICK L
    Transfusion; 1964; 4():382-3. PubMed ID: 14205860
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-ce (anti-f) in a CDe-cD-mother, as a cause of haemolytic disease of the newborn.
    Spielmann W; Seidl S; von Pawel J
    Vox Sang; 1974; 27(5):473-7. PubMed ID: 4213590
    [No Abstract]   [Full Text] [Related]  

  • 4. Unexpected suppression of anti-Fya and prevention of hemolytic disease of the fetus and newborn after administration of Rh immune globulin.
    Branch DR; Scofield TL; Moulds JJ; Swanson JL
    Transfusion; 2011 Apr; 51(4):816-9. PubMed ID: 20946183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of complement binding by anti-D and anti-M antibodies employing labelled antiglobulin antibodies.
    Freedman J; Massey A; Chaplin H; Monroe MC
    Br J Haematol; 1980 Jun; 45(2):309-18. PubMed ID: 6776980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal anti-D concentrations and outcome in rhesus haemolytic disease of the newborn.
    Bowell P; Wainscoat JS; Peto TE; Gunson HH
    Br Med J (Clin Res Ed); 1982 Jul; 285(6338):327-9. PubMed ID: 6284295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
    Kumpel BM
    Transfusion; 2006 Sep; 46(9):1652-6. PubMed ID: 16965599
    [No Abstract]   [Full Text] [Related]  

  • 8. Consequences for fetus and neonate of maternal red cell allo-immunisation.
    Howard H; Martlew V; McFadyen I; Clarke C; Duguid J; Bromilow I; Eggington J
    Arch Dis Child Fetal Neonatal Ed; 1998 Jan; 78(1):F62-6. PubMed ID: 9536844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemolytic disease due to antibodies other than anti-D.
    LEVINE P
    Rev Hematol; 1955; 10(2):215-26; discussion, 256-64. PubMed ID: 13255416
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hemolytic disease of the newborn caused by maternal irregular antibody anti-E: report of one case].
    Liu YJ; Lee BF; Lin YZ; Chen W; Wu KW; Lin MC
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1990; 31(5):332-5. PubMed ID: 2260470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case for the antenatal administration of anti-D immunoglobulin to primigravidae.
    Tovey LA; Taverner JM
    Lancet; 1981 Apr; 1(8225):878-81. PubMed ID: 6112301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rhesus haemolytic disease.
    Whittle MJ
    Arch Dis Child; 1992 Jan; 67(1 Spec No):65-8. PubMed ID: 1536591
    [No Abstract]   [Full Text] [Related]  

  • 13. Persistence of maternal anti-Rh (anti-D) in an Rh-positive infant.
    NORRIS HJ; YUNIS E
    J Lancet; 1963 Jun; 83():243-4. PubMed ID: 13938968
    [No Abstract]   [Full Text] [Related]  

  • 14. More on the R0 Har antigenic complex.
    Case J
    Transfusion; 1996; 36(11-12):1034-5. PubMed ID: 8937417
    [No Abstract]   [Full Text] [Related]  

  • 15. An Rho-positive mother with serum containing potent Rh antibodies apparently of specificity anti-Rho, causing erythroblastosis fetalis.
    GEIGER J; WIENER AS
    Bibl Haematol; 1958; 7():36-40. PubMed ID: 13499221
    [No Abstract]   [Full Text] [Related]  

  • 16. Erythrocyte glycolysis in erythroblastotic newborns. Erythrocyte glycolysis also in Rh-positive red cells coated with anti-D antibodies.
    ABRAHAMOV A; DIAMOND LK
    AMA J Dis Child; 1960 Feb; 99():202-5. PubMed ID: 13791535
    [No Abstract]   [Full Text] [Related]  

  • 17. Occurrence of anti-D in RhD-positive mothers and the outcome of the newborns.
    Filbey D; Berseus O; Carlberg M
    Acta Obstet Gynecol Scand; 1996 Jul; 75(6):585-7. PubMed ID: 8693938
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro studies of red cell fragility in anti-D hemolytic disease of the newborn.
    GREENWALT TJ; TRIANTAPHYLLOPOULOS DC
    J Lab Clin Med; 1955 Jan; 45(1):135-40. PubMed ID: 13233638
    [No Abstract]   [Full Text] [Related]  

  • 19. [Inhibition of anti-D immunoglobulins].
    Guimbretière J; Guimbretière L
    Rev Fr Transfus; 1969; 12(1):Suppl:323-9. PubMed ID: 4193518
    [No Abstract]   [Full Text] [Related]  

  • 20. [Significance of alloantibodies other than anti-D hemolytic disease of the fetus and newborn (HDF/N)].
    Lenkiewicz B; Zupańska B
    Ginekol Pol; 2003 Jan; 74(1):48-54. PubMed ID: 12715437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.